EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma.
- DOI
- 10.1158/1535-7163.mct-23-0096
- Published
- 2023-12-01
- Container
- Mol Cancer Ther
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-23-0096,
title = {EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma.},
author = {Shen B and Shi JP and Zhu ZX and He ZD and Liu SY and Shi W and Zhang YX and Ying HY and Wang J and Xu RF and Fang F and Chang HX and Chen Z and Zhang NN.},
year = {2023},
journal = {Mol Cancer Ther},
doi = {10.1158/1535-7163.mct-23-0096},
url = {https://doi.org/10.1158/1535-7163.mct-23-0096}
}RIS
TY - JOUR TI - EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma. AU - Shen B AU - Shi JP AU - Zhu ZX AU - He ZD AU - Liu SY AU - Shi W AU - Zhang YX AU - Ying HY AU - Wang J AU - Xu RF AU - Fang F AU - Chang HX AU - Chen Z AU - Zhang NN. PY - 2023 JO - Mol Cancer Ther DO - 10.1158/1535-7163.mct-23-0096 UR - https://doi.org/10.1158/1535-7163.mct-23-0096 ER -
APA
B, S., JP, S., ZX, Z., ZD, H., SY, L., W, S., YX, Z., HY, Y., J, W., RF, X., F, F., HX, C., Z, C., & NN., Z. (2023). EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma.. Mol Cancer Ther. https://doi.org/10.1158/1535-7163.mct-23-0096
Source records
- europe-pmc · retrieved 2026-09-27T07:08:16.231Z